Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 Pogledi
• 07/14/23
0
0
Ugraditi
administrator
Pretplatnici
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari